Pulse Biosciences, Inc. PLSE Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -80.7%-2.9pp | -74.4%— | -87%— | -103.5%— | -77.9%— | |
| Return on invested capital | -1,211.5%-506pp | -1,168.1%-411pp | -1,141.3%-646pp | -914.4%— | -705.7%— | |
| Efficiency | ||||||
| Asset turnover | 0×— | 0×— | 0×— | 0×— | 0×— | |
| Liquidity | ||||||
| Current ratio | 7.3×-8.3× | 10.5×-1.4× | 10×-1.9× | 12×+7.5× | 15.6×+8.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.2× | 0.1×-0.2× | |
| Valuation | ||||||
| Market capitalization | $1.47B+38.4% | $930.45M-13.1% | $1.19B+18.8% | $1.04B+67.8% | $1.06B+121% | |
| Price / book | 22.1×+13.2× | 11.5×+2.2× | 12.9×+0.2× | 9.9×-13.0× | 9×-4.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -4067.5% gross margin and a -10392.1% operating margin, with a -9929.0% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
